Abstract
The F-ATP synthase is an essential enzyme in mycobacteria, including the pathogenic Mycobacterium tuberculosis. Several new compounds in the TB-drug pipeline target the F-ATP synthase. In light of the importance and pharmacological attractiveness of this novel antibiotic target, tools have to be developed to generate a recombinant mycobacterial F1FO ATP synthase to achieve atomic insight and mutants for mechanistic and regulatory understanding as well as structure-based drug design. Here, we report the first genetically engineered, purified and enzymatically active recombinant M. smegmatis F1FO ATP synthase. The projected 2D- and 3D structures of the recombinant enzyme derived from negatively stained electron micrographs are presented. Furthermore, the first 2D projections from cryo-electron images are revealed, paving the way for an atomic resolution structure determination.
Original language | English |
---|---|
Pages (from-to) | 374-380 |
Number of pages | 7 |
Journal | Biochemical and Biophysical Research Communications |
Volume | 522 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 5 2020 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2019 Elsevier Inc.
ASJC Scopus Subject Areas
- Biophysics
- Biochemistry
- Molecular Biology
- Cell Biology
Keywords
- Bioenergetics
- Drug discovery
- Electron microscopy
- F-ATP synthase
- Mycobacterium
- Tuberculosis